Intrinsic Value of S&P & Nasdaq Contact Us

Atlantic International Corp. ATLN NASDAQ

NASDAQ Global Market • Healthcare • Medical - Diagnostics & Research • US • USD

SharesGrow Score
31/100
1/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

Atlantic International Corp. (ATLN) has a negative trailing P/E of -1.7, meaning the company is currently unprofitable on a trailing twelve-month (TTM) basis. Trailing earnings yield is -59.68%.

Criteria proven by this page:

  • VALUE (100/100, Pass) — composite valuation score exceeds the 60/100 pass threshold.
  • Trailing Earnings Yield -59.68% — negative yield confirms the company is currently unprofitable. Investors are paying for a turnaround rather than current earnings.

Overall SharesGrow Score: 30/100 with 1/7 criteria passed.

SharesGrow 7-Criteria Score
31/100
SG Score
View full scorecard →
VALUE
100/100
Price-to-Earnings & upside
Proven by this page
FUTURE
N/A
No coverage
PAST
0/100
→ Income
HEALTH
0/100
Debt-to-Equity & liquidity
→ Health
MOAT
15/100
→ Income
~
GROWTH
58/100
→ Income
INCOME
10/100
→ Income

Valuation Snapshot — ATLN

Valuation Multiples
P/E (TTM)-1.7
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio-7.66
P/S Ratio0.55
EV/EBITDA-5.1
Per Share Data
EPS (TTM)$-1.85
Book Value / Share$-0.40
Revenue / Share$8.16
FCF / Share$0.06
Yields & Fair Value
Earnings Yield-59.68%
Dividend Yield0.00%

Historical Valuation

Year P/E (TTM) PEG Ratio P/B Ratio P/S Ratio Dividend Yield
2016 -1,973.0 0.00 -17,858.41 3,011.68 -
2017 -1,658.0 -84.74 -1,613.12 2,113.93 -
2018 -1,342.4 -49.22 -10,032.63 4,976.12 -
2019 -1,567.3 109.71 -1,370.35 7,271.67 -
2020 -3,708.5 62.68 -1,005.86 11,765.70 -
2021 -39.8 -0.16 198.31 3.82 -
2022 -78.4 -6.66 57.82 0.57 -
2023 -7.1 -0.03 -2.75 0.27 -
2024 -1.3 0.00 -14.94 0.41 -

EPS: Actual vs Estimates

P/E Ratio & Earnings Yield

Earnings Per Share (EPS) History

Year EPS (Diluted) Revenue Net Income Net Margin
2016 $-4.90 $939.68K $-1.43M -152.6%
2017 $-5.84 $1.34M $-1.71M -127.5%
2018 $-9.88 $779.07K $-2.89M -370.7%
2019 $-8.46 $533.13K $-2.47M -464%
2020 $-3.57 $329.5K $-1.05M -317.3%
2021 $-12.46 $210K $-3.7M -1763.6%
2022 $-12.38 $78.66K $-4.09M -5205.8%
2023 $-39.99 $401.37M $-15.25M -3.8%
2024 $-121.27 $442.61M $-135.48M -30.6%

Analyst Estimates

Year EPS (Avg) EPS Range Revenue (Avg) Revenue Range Analysts
2026 $-0.61 $-0.61 – $-0.61 $481.08M $481.08M – $481.08M 1
2027 $-11.60 $-11.60 – $-11.60 $37.54M $37.54M – $37.54M 1
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message